XOMA Corp
NASDAQ:XOMA
XOMA Corp
NASDAQ:XOMA
Price:
34.58
USD
2.46%
Market Closed
Market Cap:
$428.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
XOMA Corp
NASDAQ:XOMA
|
US |
|
Thinkingdom Media Group Ltd
SSE:603096
|
CN |
|
Arovella Therapeutics Ltd
ASX:ALA
|
AU |
|
F
|
Fore Kopi Indonesia PT Tbk
IDX:FORE
|
ID |
|
D
|
Daeyang Electric Co Ltd
KOSDAQ:108380
|
KR |
|
C
|
ChemX Materials Ltd
ASX:CMX
|
AU |
|
Remsons Industries Ltd
NSE:REMSONSIND
|
IN |
|
P
|
Pureun Mutual Savings Bank
KOSDAQ:007330
|
KR |
|
Alamos Gold Inc
TSX:AGI
|
CA |
|
Schindler Holding AG
SIX:SCHN
|
CH |
|
Jindal SAW Ltd
NSE:JINDALSAW
|
IN |
|
Zoom Corp
TSE:6694
|
JP |
|
Orell Fuessli AG
SIX:OFN
|
CH |
Multiples-Based Value
The
Multiples-Based Value for
XOMA Corp (XOMA)
under the Base Case is
hidden
USD.
Compared with the current market price of 34.58 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
XOMA Multiples-Based Value
LOCKED
Multiples Across Competitors
XOMA Competitors Multiples
XOMA Corp Competitors
XOMA Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
XOMA Corp
NASDAQ:XOMA
|
410.1m USD | 7.9 | 22.1 | 29.5 | 37.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6 | 87.2 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5 | 23.7 | 13.8 | 13.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.1 | 27.7 | 20.8 | 21.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.6 | 17.8 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.1 | 11.1 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.3 | 36.2 | 39.4 | 40.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
